Related Experiment Video
Updated: Feb 11, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Turning Cold Tumors Hot by Blocking TGF-β
Xavier Romero Ros1, Louis Vermeulen1
1Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam and Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Abstract:
Novel immune therapeutic tools are rapidly expanding the anticancer arsenal. Despite this progress, patients with colorectal cancer (CRC) that spreads to vital parts of the body still have a dismal outcome. Transforming growth factor-β (TGF-β) plays a pivotal role in the development of CRC and metastasis. Important new work by Tauriello and colleagues has revealed that inhibition of TGF-β prevents tumor metastasis by enhancing a cytotoxic T cell response, suggesting that TGF-β inhibition is a promising pro-immunogenic therapy.
Insights
Novel therapies target colorectal cancer (CRC) metastasis. Inhibiting transforming growth factor-beta (TGF-β) enhances T cell responses, offering a promising strategy to combat advanced CRC and prevent its spread.
Area of Science:
- Oncology
- Immunology
- Cancer Metastasis
Background:
- Colorectal cancer (CRC) metastasis remains a significant challenge with poor patient outcomes.
- Transforming growth factor-beta (TGF-β) is a key mediator in CRC progression and metastasis.
- Current therapeutic options for metastatic CRC are limited.
Purpose of the Study:
- To investigate the role of TGF-β in colorectal cancer metastasis.
- To evaluate the potential of TGF-β inhibition as an anticancer therapy.
- To determine the impact of TGF-β inhibition on the tumor immune microenvironment.
Main Methods:
- Utilized preclinical models of colorectal cancer metastasis.
- Administered TGF-β inhibitors to assess their therapeutic effects.
- Analyzed changes in the immune cell populations, specifically cytotoxic T cells, within the tumor microenvironment.
Main Results:
- Inhibition of TGF-β effectively suppressed colorectal cancer metastasis.
- TGF-β blockade led to a significant enhancement of cytotoxic T cell responses against tumor cells.
- This suggests a mechanism where TGF-β normally suppresses anti-tumor immunity.
Conclusions:
- Targeting TGF-β represents a promising immunogenic therapy for colorectal cancer.
- Inhibiting TGF-β can overcome immune suppression and promote anti-tumor immunity.
- This approach holds potential for improving treatment outcomes in patients with metastatic CRC.
Related Concept Videos
TGF - β Signaling Pathway
Masonry in Cold and Hot Weather Conditions
Other key practices include keeping masonry units...
Hot Weather Concreting
Mitigating the heat increase in concrete can be economically achieved by shading aggregate stockpiles to prevent heating from solar radiation,...
Responses to Heat and Cold Stress
Cold Weather Concreting
To counteract the negative impacts of cold weather, ensuring...
Block Diagram Reduction
The first step in this process is the identification and relocation of a branch point. A branch point, where a...

